Table 1.
Demographic and clinical characteristics of EPOCH participants at second study visit
| Characteristic | Overall |
|---|---|
| n | 356 |
| Age, years | 16.9 (15.9, 17.6) |
| Male sex | 178 (50.0) |
| Race | |
| White | 307 (86.2) |
| Black/African American | 29 (8.1) |
| Other | 20 (5.6) |
| Hispanic ethnicity | 120 (33.7) |
| Hispanic White | 112 (93.3) |
| Hispanic Black/African American | 5 (4.2) |
| Hispanic other | 3 (2.5) |
| Intrauterine exposure to maternal diabetes | 65 (18.3) |
| BMI, kg/m2 | 22.0 (19.8, 25.2) |
| BMI category | |
| Normal weight | 257 (72.2) |
| Overweight | 44 (12.4) |
| Obese | 55 (15.4) |
| BMI z score | 0.3 (−0.4, 1.2) |
| Weighted T2D GRS | 0.0 (−0.6, 0.7) |
| Unweighted T2D GRS | 0.0 (−0.7, 0.7) |
| Fasting glucose, mmol/L | 4.9 (4.7, 5.2) |
| 2-h glucose, mmol/L | 5.0 (4.3, 5.8) |
| HOMA-IR | 3.0 (2.3, 4.2) |
| Oral disposition index | 2.8 (1.9, 4.8) |
| Insulinogenic index | 5.8 (3.5, 9.8) |
| Prediabetes | 24 (7.2) |
| Impaired fasting glucose (≥5.6 mmol/L) | 18 (5.1) |
| Impaired glucose tolerance (≥7.8 mmol/L) | 9 (2.7) |
Values are presented as median (interquartile range) or n (%).